Atlas Trials

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Clinical trial NCT02435992 · COMPLETED

Trial details

NCT number
NCT02435992
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2015-06-17
Primary completion
2020-03-27
Enrollment
1012

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.